Iron deficiency anemia (IDA) continues to be very common worldwide. Intravenous (IV) iron is an infrequently used therapeutic option in children with IDA despite numerous studies in adults and several small but notable pediatric studies showing efficacy and safety. Presently, the availability of newer IV iron products allows for replacement of the total iron deficit at a single setting.
ReTweet if useful... Intravenous iron therapy for paediatric patients http://ctt.ec/sPU79+ @ivteam #ivteam
These products appear safer compared to the high molecular weight iron dextrans of the past. Herein, we review the medical literature and suggest that front line use of IV iron should be strongly considered in diseases associated with IDA in children.
Mantadakis, E. (2015) Advances in Pediatric Intravenous Iron Therapy. Pediatric Blood & Cancer. September 16th. [epub ahead of print].
Thank you to our partners for supporting IVTEAM